The American College of Rheumatology and the Arthritis Foundation have released updated recommendations for the screening, monitoring, and treatment of juvenile idiopathic arthritis with associated uveitis.
The TRACE RA study showed that atorvastatin significantly reduced LDL cholesterol in patients with rheumatoid arthritis.
The ACR has released updated drug pricing and step therapy position statements.
The International Consensus on Antinuclear Antibody Patterns initiative has reached consensus regarding the clinical relevance of distinct patterns of indirect immunofluorescence assay on HEp-2 cells.
The FDA has released an updated draft guidance that will update the naming convention of biologic medications.
Pfizer has announced its intention to transition patients with rheumatoid arthritis who were receiving tofacitinib 10 mg twice daily to receive tofacitinib 5 mg twice daily in its post-marketing study.
